FDA Warns Edwards Over Heart Device Reporting

By Allison Grande

Law360, New York (April 08, 2010, 2:56 PM ET) -- The U.S. Food and Drug Administration has hit Edwards Lifesciences LLC with a warning over the company's alleged inability to properly and timely report six complaints of adverse events linked to its annuloplasty ring devices and a pericardial heart valve device.

The FDA on Tuesday released the warning letter sent to Edwards' Irvine, Calif., headquarters on March 1 alerting the company that the devices are misbranded under the Federal Food, Drug and Cosmetic Act due to its inadequate reporting of these complaints.

The agency discovered these...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles